Release Date: 13/05/16 16:39 Summary: Extension of Offer Period-BRS.AX Price Sensitive: Yes Download Document 117.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%